For Authors

The editor is pleased to consider manuscripts on a wide range of topics related to the publication’s mission. There are no fees or charges associated with submitting to or publishing your manuscript in _Pharmacy Practice in Focus: Oncology_™ (_PPFO_).

If you have questions about the manuscript submission process or wish to speak to an editor, please email Alexandra Gerlach (agerlach@mjhlifesciences.com).

Article types

Original research: 1000 word minimum and 5000 word maximum (excluding abstract, references, tables, etc). These should contain no more than 5 combined graphic elements (tables/figures) and no more than 50 references. Supplemental data (extra tables, figures, or appendices) will be made available at [www.pharmacytimes.com](on www.pharmacytimes.com) at the time of publication.

Literature review: 1000 word minimum and 5000 word maximum. These should present a thorough synthesis of the literature and offer new insights and/or recommendations on how to improve the standard of care. These should contain no more than 5 graphic elements and no more than 100 references.

New drug review: 1000 word minimum and 5000 word maximum. These should present a thorough synthesis of data and literature on a new drug that has become or is becoming available, with insights and/or recommendations on the standard of care. These should contain no more than 2 graphic elements and no more than 100 references.

Case description: 1000 word minimum and 2000 word maximum. These should provide case analysis of a single organization’s efforts or practices. These reports should contain no more than 2 graphic elements and no more than 30 references.

Case report: 1000 word minimum and 2000 word maximum. These should provide analysis of a clinical case and the treatment and care for the patient(s), often because of the unique nature of the patient case. These reports should contain no more than 2 graphic elements and no more than 30 references.

Insights: 800 word minimum and 1500 word maximum. These are usually solicited from recognized thought leaders that discuss pertinent and sometimes controversial issues in health care. These should contain no more than 2 graphic elements and no more than 30 references.

Editorial: 600 word minimum and 1000 word maximum. These are solicited to accompany key articles and either extend or offer opposing perspectives on a specific subject. These should contain no more than 1 table or figure and no more than 10 references.

Letter to the editor: 600 word minimum and 1000 word maximum. These are published as space allows. These should contain no more than 1 table or figure and no more than 10 references.

Submission requirements

_Manuscript Specifications_
-Title (<10 words) should be concise and stimulate reader interest
-Running head (about 5-8 words)
-Abstract (≤250 words)
-If Original Research, the abstract must include 5 paragraphs: Objectives, Study Design,
Methods, Results, and Conclusions
-Precis (<25 words, concise summary of the article)
-Full names of each author, followed by their highest academic degree and additional credentials
-Institutional affiliations and titles for each author
-Name and email information of corresponding author

Text. Article text should be in a Word document in 12-pt font size, with citations included throughout the article with a corresponding list of references at the end of the article following AMA Manual of Style (11th edition). Any tables, figures, and legends included with the article can either be placed in the article document or submitted alongside the article as a jpeg or gif. Cited references, tables, and figures should be in sequential order.

Abbreviations or acronyms must be spelled out in full on first appearance in the text, followed by its abbreviation in parentheses. Additionally, state the generic name (not the trade/brand name) for all pharmaceutical products, with the trade/brand name and manufacturer in parentheses following the first mention of the pharmaceutical product.

References. It is the responsibility of the authors to include and verify all references, which should conform to the AMA Manual of Style (11th edition). Also, as specified by International Committee of Medical Journal Editors (ICMJE), authors should not cite AI and AI-assisted technologies as an original resource or reference. Additionally, for any areas where AI and AI-assisted technologies were used in the development of the paper, humans must ensure that there is appropriate attribution of all quoted material with full citations.

References should be cited in the text sequentially as a superscripted number after any punctuation mark. Two references are cited separated by a comma, with no space. Three or more consecutive references are given as a range with a hyphen.

Per AMA style, references should be numbered sequentially in the order they appear in the text (do not alphabetize author names in the references). Identify references with superscript Arabic numerals. References cited only in tables or figures should be numbered in accordance with the sequence established by the first mention of that particular table or figure in the text.

In the reference list, list authors and/or editors up to 6 names; if more than 6 authors, list the first 3 followed by et al. Journal references should include the issue number in parentheses after the volume number. Journal names should be abbreviated according to the journals list in PubMed.

References to papers accepted but not yet published should be designated as “in press” and included in the reference section. Information from articles submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source. Reference for “personal communication” that provides essential information not available from a public source, should include the name of the person, his or her degree, and the date of communication should be cited in parentheses in the text. In text, do not use footnotes; instead include them in parentheses in the body of the article. (Footnotes should only be used in tables and figures.)

The clinicaltrials.gov page must be cited for referenced clinical trials in-text, as well as in the references. In-text citations should be written as follows: (NCT05060016).